哌嗪类化合物是指含有哌嗪结构的一类重要医药中间体,广泛应用于生产驱肠虫药物如磷酸哌嗪和枸橼酸哌嗪,以及氟奋乃静、强痛定和利福平等其他药物。此外,这些化合物也被用于制造湿润剂、乳化剂、分散剂等表面活性剂,以及抗氧剂、防腐剂、稳定剂等塑料加工助剂与橡胶助剂。
哌嗪又名六氢吡嗪或二亚乙基二胺。从乙醇中析出的哌嗪为白色斜方晶系叶片状结晶,具有温和的胺臭和咸味,并具备吸湿性。其相对密度为0.876,熔点为106.6℃,沸点为146℃。该化合物易溶于水和甘油,微溶于乙醇而不溶于乙醚。哌嗪具有强碱性,10%的水溶液pH值在10.8~11.8之间,并能吸收空气中的二氧化碳。对眼睛和皮肤有刺激作用,具有典型的仲胺反应。它可通过乙二胺与1,2-二氯乙烷反应或由氨基乙醇高温下二聚而制得。无机酸及有机酸盐用作人和动物的驱肠虫药物,是驱除蛔虫、蛲虫的有效药物,并用于有机合成。
哌嗪又称为“驱蛔灵”,对蛔虫和蛲虫均有较强作用。该药能使虫体肌肉发生松弛性麻痹,防止其随肠道蠕动被排出体外。使用时不会出现兴奋现象,相对安全。可用于治疗由蛔虫引起的不完全肠梗阻及早期胆道蛔虫病,亦适用于伴有溃疡病的患者。一般剂量治愈率可达70%~80%,连续用药2天可提高治愈率。治疗蛲虫病需连续服药7~10天。该药物毒性较低,治疗量下偶尔会出现恶心、呕吐或荨麻疹等副作用。
| 中文名称 | 英文名称 | CAS号 | 化学式 |
|---|---|---|---|
| 1-(4-硝基苯基)哌嗪-2-酮 | 1-(4-nitrophenyl)piperazin-2-one | 867166-73-2 | C10H11N3O3 |
| 1-(4-硝基苯基)哌嗪 | 1-(4-Nitrophenyl)piperazine | 6269-89-2 | C10H13N3O2 |
| 1-(4-甲氧基苯基)哌嗪 | 1-(4-methoxyphenyl)piperazine | 38212-30-5 | C11H16N2O |
| 1-(4-甲氧基苯基)-4-(4-硝基苯基)哌嗪 | 1-(4-methoxyphenyl)-4-(4-nitrophenyl)-piperazine | 74852-61-2 | C17H19N3O3 |
| 1-(4-溴苯基)哌嗪 | 1-(4-bromophenyl)piperazine | 66698-28-0 | C10H13BrN2 |
| 1-(4-溴苯基)-4-甲基哌嗪 | 1-(4-bromophenyl)-4-methylpiperazine | 130307-08-3 | C11H15BrN2 |
| 1-(4-溴苄基)哌嗪 | 1-(4-bromobenzyl)piperazine | 91345-62-9 | C11H15BrN2 |
| 1-(4-溴-2-氟苄基)哌嗪 | 1-(4-bromo-2-fluorobenzyl)piperazine | 870703-75-6 | C11H14BrFN2 |
| 1-(4-氰基苄基)哌嗪 | 4-(piperazin-1-ylmethyl)benzonitrile | 89292-70-6 | C12H15N3 |
| 1-(4-氨基苯基)-4-(4-甲氧基苯基)哌嗪 | 4-(4-(4-methoxyphenyl)piperazin-1-yl)aniline | 74852-62-3 | C17H21N3O |
| 1-(4-氟苯基)哌嗪盐酸盐 | 1-(4-Fluorophenyl)piperazine dihydrochloride | 64090-19-3 | C10H15Cl2FN2 |
| 1-(4-哌啶基)哌嗪三盐酸盐 | 1-(Piperidin-4-YL)piperazine trihydrochloride | 1217074-64-0 | C9H22Cl3N3 |
| 1-(4,4'-二氯二苯甲基)哌嗪 | 1-(4,4'-dichloro-benzhydryl)-piperazine | 27469-61-0 | C17H18Cl2N2 |
| 1-(3-硝基苯基)哌嗪 | 1-(3-nitrophenyl)piperazine | 54054-85-2 | C10H13N3O2 |
| 1-(3-甲磺基)丙基哌嗪盐酸盐 | 4-[3-(methylsulfonyl)propyl]-piperazine | 910572-80-4 | C8H18N2O2S |
| 1-(3-甲氧基-4-硝基苯基)-4-甲基哌嗪 | 1-(3-methoxy-4-nitrophenyl)-4-methylpiperazine | 761440-26-0 | C12H17N3O3 |
| 1-(3-甲基苯甲基)哌嗪 | 1-(3-methylbenzyl)piperazine | 5321-48-2 | C12H18N2 |
| 1-(3-溴苯基)哌嗪盐酸盐 | 1-(3-bromophenyl)piperazine hydrochloride | 796856-45-6 | C10H13BrN2*ClH |
| 1-(3-氨丙基)-4-甲基哌嗪 | 3-(N-methylpiperazino)propylamine | 4572-03-6 | C8H19N3 |
| 1-(3-氧杂环丁基)哌嗪 | 1-(oxetan-3-yl)piperazine | 1254115-23-5 | C7H14N2O |
| 1-(3,4-二甲基苯基)哌嗪 | 1-(3,4-dimethylphenyl)piperazine | 1014-05-7 | C12H18N2 |
| 1-(2-苯甲腈)哌嗪 | 2-(piperazin-1-yl)benzonitrile | 111373-03-6 | C11H13N3 |
| 1-(2-苄氧基乙基)-哌嗪 | 1-(2-(benzyloxy)ethyl)piperazine | 4981-85-5 | C13H20N2O |
| 1-(2-羟基苯基)哌嗪 | 2-hydroxyphenylpiperazine | 1011-17-2 | C10H14N2O |
| 1-(2-羟基-1-氧代丙基)哌嗪 | 2-hydroxy-1-(piperazin-1-yl)propan-1-one | 100500-89-8 | C7H14N2O2 |
| 1-(2-羟乙基)-4-甲基哌嗪 | 2-(4-methylpiperazinyl)ethanol | 5464-12-0 | C7H16N2O |
| 1-(2-糠酰)哌嗪 | N-(furan-2-carbonyl)piperazine | 40172-95-0 | C9H12N2O2 |
| 1-(2-甲氧苯基)哌嗪溴酸盐 | 1-(2-methoxyphenyl)piperazine hydrobromide | 100939-96-6 | BrH*C11H16N2O |
| 1-(2-甲氧苯基)哌嗪 | 1-(2-Methoxyphenyl)piperazine | 35386-24-4 | C11H16N2O |
| 1-(2-甲氧基-2-苯基)乙基哌嗪 | 1-(2-methoxy-2-phenyl-ethyl)-piperazine | 6722-54-9 | C13H20N2O |
| 1-(2-甲基苯甲基)哌嗪 | 1-(2-methylbenzyl)piperazine | 5321-47-1 | C12H18N2 |
| 1-(2-甲基苯基)哌嗪 | 1-(o-toluyl)piperazine | 39512-51-1 | C11H16N2 |
| 1-(2-甲基-2-丙基)-2-哌嗪酮 | 1-tert-butylpiperazin-2-one | 681483-76-1 | C8H16N2O |
| 1-(2-溴乙基)-4-甲基哌嗪二氢溴化物 | 1-(2-Bromoethyl)-4-methylpiperazine dihydrobromide | 5845-28-3 | C7H17Br3N2 |
| 1-(2-氯苯基)哌嗪 | N-(o-Chlorophenyl)piperazine | 39512-50-0 | C10H13ClN2 |
| 1-(2-氯乙基)-4-[3-(三氟甲基)苯基]哌嗪二盐酸盐 | N-(3-trifluoromethylphenyl)-N'-(2-chloroethyl)-piperazine | 57061-71-9 | C13H16ClF3N2 |
| 1-(2-氟苯基)哌嗪 | 1-(o-fluorophenyl)piperazine | 1011-15-0 | C10H13FN2 |
| 1-(2,4-二氯苯基)哌嗪 | 1-(2,4-Dichloro-benzyl)-piperazine hydrochloride | 6270-11-7 | C11H15Cl3N2 |
| 1-(2,4-二氯苯基)哌嗪 | 1-(2,4-dichlorobenzyl)piperazine | 51619-56-8 | C11H14Cl2N2 |
| 1-(2,4-二氟苯基)哌嗪 | 1-(2,4-difluoro-phenyl)piperazine | 115761-79-0 | C10H12F2N2 |
| 1-(2,3-二氯苯基)哌嗪 | 1-(2,3-dichloro-phenyl)-piperazine | 41202-77-1 | C10H12Cl2N2 |
| 1-(2,2-二氟乙基)哌嗪 | 1-(2,2-difluoroethyl)piperazine | 767609-14-3 | C6H12F2N2 |
| 1-(2,2,2-三氟乙基)哌嗪二盐酸盐 | 1-(2,2,2-Trifluoroethyl)piperazine dihydrochloride | 13349-91-2 | C6H13Cl2F3N2 |
| 1-(1-萘甲基)哌嗪 | 1-naphthalen-1-ylmethyl-piperazine | 40675-81-8 | C15H18N2 |
| 1-(1-甲基哌啶-4-基)哌嗪三盐酸盐 | 1-(1-methylpiperidin-4-yl)piperazine hydrochloride | 349535-15-5 | C10H21N3*ClH |
| 1-(1-甲基哌啶-4-基)哌嗪 | 1-(1-methyl-piperidin-4-yl)-piperazine | 23995-88-2 | C10H21N3 |
| 1,4-哌嗪二丙氰 | 3-[4-(2-cyanoethyl)piperazin-1-yl] propanenitrile | 4159-11-9 | C10H16N4 |
| 1,4-双(2-异氰丙基)哌嗪 | 1,4-bis(3-isocyanopropyl)piperazine | 51641-96-4 | C12H20N4 |
| 1,4-双(7-氯喹啉-4-基)哌嗪 | AN-740/37278004 | 31502-87-1 | C22H18Cl2N4 |
| 1,4-双(4-氨基苯基)哌嗪 | 4-(4-(4-aminophenyl)piperazin-1-yl)benzenamine | 7479-12-1 | C16H20N4 |